Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABX Barrick Gold	C$28.35 +1.1%	C$26.99	C$21.73 ▼ C$29.50	C$34.46B	0.48	3.71 million shs	2.17 million shs
ACAD ACADIA Pharmaceuticals	$21.57 -2.5%	$19.74	$13.40 ▼ $25.23	$3.70B	0.64	1.96 million shs	1.63 million shs
AIZ Assurant	$197.68 +0.4%	$197.52	$160.12 ▼ $230.55	$10.01B	0.61	429,238 shs	419,348 shs
SFIX Stitch Fix	$3.70 +4.8%	$3.95	$2.21 ▼ $6.99	$460.62M	2	2.43 million shs	1.83 million shs
TACO Berto Acquisition	$10.42 +0.3%	$12.50	$7.34 ▼ $12.56	$339.90M	N/A	485,177 shs	175,834 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABX Barrick Gold	+1.14%	-2.51%	+8.08%	+0.75%	+24.23%
ACAD ACADIA Pharmaceuticals	-2.49%	-4.05%	-0.14%	+32.17%	+32.74%
AIZ Assurant	+0.44%	-0.91%	-2.62%	-6.38%	+18.91%
SFIX Stitch Fix	+4.82%	-4.15%	-15.72%	+11.45%	-10.84%
TACO Berto Acquisition	0.00%	-2.81%	-16.95%	-16.95%	-16.95%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABX Barrick Gold	1.5111 of 5 stars	2.4	0.0	1.7	0.0	0.0	1.7	1.3
ACAD ACADIA Pharmaceuticals	4.5922 of 5 stars	4.4	3.0	0.0	0.0	2.6	4.2	2.5
AIZ Assurant	4.9216 of 5 stars	2.4	5.0	4.2	3.3	2.8	2.5	2.5
SFIX Stitch Fix	3.458 of 5 stars	3.0	1.0	0.0	2.0	3.4	3.3	0.0
TACO Berto Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABX Barrick Gold	2.85	Moderate Buy	C$33.67	18.75% Upside
ACAD ACADIA Pharmaceuticals	2.71	Moderate Buy	$27.88	29.23% Upside
AIZ Assurant	2.83	Moderate Buy	$228.67	15.68% Upside
SFIX Stitch Fix	2.00	Hold	$5.67	53.15% Upside
TACO Berto Acquisition	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest ABX, AIZ, ACAD, SFIX, and TACO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/26/2025	ACAD ACADIA Pharmaceuticals	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform	$19.00 ➝ $22.00
6/26/2025	ACAD ACADIA Pharmaceuticals	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$37.00
6/26/2025	ACAD ACADIA Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00
6/26/2025	ACAD ACADIA Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$32.00
6/23/2025	ACAD ACADIA Pharmaceuticals	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$26.00 ➝ $38.00
6/11/2025	SFIX Stitch Fix	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform	$6.00
6/6/2025	ACAD ACADIA Pharmaceuticals	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$26.00 ➝ $30.00
6/5/2025	ACAD ACADIA Pharmaceuticals	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/5/2025	ACAD ACADIA Pharmaceuticals	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Hold	$18.00 ➝ $23.00
6/4/2025	SFIX Stitch Fix	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform	$6.00
5/21/2025	ACAD ACADIA Pharmaceuticals	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$20.00 ➝ $35.00

(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABX Barrick Gold	C$8.51B	4.05	C$3.92 per share	7.23	C$18.67 per share	1.52
ACAD ACADIA Pharmaceuticals	$957.80M	3.77	$0.69 per share	31.38	$4.40 per share	4.90
AIZ Assurant	$11.88B	0.85	$21.51 per share	9.19	$99.57 per share	1.99
SFIX Stitch Fix	$1.34B	0.36	N/A	N/A	$1.47 per share	2.52
TACO Berto Acquisition	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABX Barrick Gold	C$1.12B	C$1.33	21.35	∞	2.34	13.19%	6.90%	4.00%	N/A
ACAD ACADIA Pharmaceuticals	$226.45M	$1.37	15.74	28.38	4.77	22.97%	17.46%	10.75%	8/5/2025 (Estimated)
AIZ Assurant	$760.20M	$12.83	15.41	10.34	N/A	5.55%	15.49%	2.29%	8/5/2025 (Estimated)
SFIX Stitch Fix	-$128.84M	-$0.46	N/A	N/A	N/A	-4.44%	-18.15%	-7.21%	N/A
TACO Berto Acquisition	N/A	$0.53	19.66	18.95	N/A	N/A	N/A	N/A	N/A

Latest ABX, AIZ, ACAD, SFIX, and TACO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
6/11/2025	Q3 2025	SFIX Stitch Fix	-$0.11	-$0.06	+$0.05	N/A	N/A	N/A
6/10/2025	Q3 2025	SFIX Stitch Fix	-$0.12	-$0.06	+$0.06	-$0.06	$315.03 million	$325.02 million
5/7/2025	Q1 2025	ACAD ACADIA Pharmaceuticals	$0.10	$0.11	+$0.01	$0.11	$239.32 million	$244.32 million
5/6/2025	Q1 2025	AIZ Assurant	$2.78	$3.39	+$0.61	$2.83	$3.06 billion	$3.07 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABX Barrick Gold	C$0.54	1.90%	N/A	40.66%	N/A
ACAD ACADIA Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
AIZ Assurant	$3.20	1.62%	N/A	24.94%	21 Years
SFIX Stitch Fix	N/A	N/A	N/A	N/A	N/A
TACO Berto Acquisition	N/A	N/A	N/A	N/A	N/A

Latest ABX, AIZ, ACAD, SFIX, and TACO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	AIZ Assurant	quarterly	$0.80	1.66%	6/9/2025	6/9/2025	6/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABX Barrick Gold	19.83	2.65	2.62
ACAD ACADIA Pharmaceuticals	N/A	2.88	2.80
AIZ Assurant	0.40	0.41	0.41
SFIX Stitch Fix	N/A	1.80	1.25
TACO Berto Acquisition	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABX Barrick Gold	62.23%
ACAD ACADIA Pharmaceuticals	96.71%
AIZ Assurant	92.65%
SFIX Stitch Fix	71.04%
TACO Berto Acquisition	N/A

Insider Ownership

Company	Insider Ownership
ABX Barrick Gold	0.60%
ACAD ACADIA Pharmaceuticals	28.30%
AIZ Assurant	0.51%
SFIX Stitch Fix	16.95%
TACO Berto Acquisition	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABX Barrick Gold	21,300	1.22 billion	N/A	Not Optionable
ACAD ACADIA Pharmaceuticals	510	167.36 million	120.00 million	Optionable
AIZ Assurant	14,200	50.87 million	50.61 million	Optionable
SFIX Stitch Fix	4,570	130.49 million	108.37 million	Optionable
TACO Berto Acquisition	7,892	32.62 million	N/A	No Data

ABX, AIZ, ACAD, SFIX, and TACO Headlines

Recent News About These Companies

Berto Acquisition Corp

June 24, 2025 | money.usnews.com

June 15, 2025 | wdrb.comW

Del Taco Signs Five-Unit Franchise Agreement in Louisville, Kentucky

June 13, 2025 | shoppingcenterbusiness.comS

Del Taco to enter Louisville market with 5-store development agreement

June 13, 2025 | bizjournals.com

Del Taco expands to Louisville with new franchise agreement

June 12, 2025 | finance.yahoo.com

Del Taco Announces Five-Store Development Agreement in Louisville, Kentucky

June 11, 2025 | businesswire.com

Is it time to invest in the real TACO trade? Mexican restaurants now outsell pizza places.

June 4, 2025 | msn.com

America's 2 biggest taco chains have roots in this little-known Calif. spot

June 4, 2025 | msn.com

Taco Bell vs Del Taco - Blind Guy Taste Test #shorts

June 3, 2025 | msn.com

7 New Taco Chains You’ll See Everywhere This Year

June 1, 2025 | eatthis.comE

Best of Staten Island 2025 results: Here are the top 3 tacos spots as chosen by our readers

May 27, 2025 | silive.comS

Jack in the Box and Del Taco say they're eyeing expansion in the Columbus area

May 23, 2025 | msn.com

‘Thanks for 20 years’: Chain’s first Idaho restaurant closes in Boise

May 23, 2025 | msn.com

Del Taco launches three new El Big Boxes in US

May 23, 2025 | msn.com

Del Taco launches brand refresh, boxes

May 21, 2025 | qsrweb.comQ

Del Taco Green Sauce | It's Only Food w/ Chef John Politte

May 21, 2025 | msn.com

Another Well Known Boise Restaurant Suddenly Closes For Good

May 20, 2025 | liteonline.comL

Florida man vandalizes Del Taco after being denied tacos at closing time

May 19, 2025 | msn.com

Port Charlotte man vandalizes Del Taco after being denied tacos at closing time

May 19, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABX, AIZ, ACAD, SFIX, and TACO Company Descriptions

Barrick Gold TSE:ABX

C$28.35 +0.32 (+1.14%)

As of 06/30/2025 04:00 PM Eastern

Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.

ACADIA Pharmaceuticals NASDAQ:ACAD

$21.57 -0.55 (-2.49%)

As of 06/30/2025 04:00 PM Eastern

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.

Assurant NYSE:AIZ

$197.68 +0.84 (+0.43%)

As of 06/30/2025 03:58 PM Eastern

Assurant, Inc., together with its subsidiaries, provides business services that supports, protects, and connects consumer purchases in North America, Latin America, Europe, and the Asia Pacific. The company operates through two segments: Global Lifestyle and Global Housing. The Global Lifestyle segment offers mobile device solutions, and extended service contracts and related services for consumer electronics and appliances, and credit and other insurance products; and vehicle protection, commercial equipment, and other related services. The Global Housing segment provides lender-placed homeowners, manufactured housing, and flood insurance; renters insurance and related products; and voluntary manufactured housing, and condominium and homeowners insurance products. The company was formerly known as Fortis, Inc. and changed its name to Assurant, Inc. in February 2004. Assurant, Inc. was founded in 1892 and is headquartered in Atlanta, Georgia.

Stitch Fix NASDAQ:SFIX

$3.70 +0.17 (+4.82%)

As of 06/30/2025 04:00 PM Eastern

Stitch Fix, Inc. sells a range of apparel, shoes, and accessories for men, women, and kids through its website and mobile application in the United States and the United Kingdom. It offers denim, dresses, blouses, skirts, shoes, jewelry, and handbags under the Stitch Fix brand. The company was formerly known as rack habit inc. and changed its name to Stitch Fix, Inc. in October 2011. Stitch Fix, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.

Berto Acquisition NASDAQ:TACO

Del Taco Restaurants, Inc. develops, franchises, owns, and operates Del Taco quick-service Mexican-American restaurants in the United States. The company's restaurants offer Mexican inspired and American classic dishes. As of August 31, 2021, it operated approximately 600 restaurants across 16 states. The company was founded in 1964 and is headquartered in Lake Forest, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time